A newly published study from a group of German researchers examined the degree to which participation in patient support group activities increased prostate cancer patients’ health literacy and, specifically, their prostate cancer‐specific and non‐cancer‐specific knowledge about health care. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: group, health, knowledge, support | Leave a comment »
A report yesterday on on the MedPage Today web site quotes Scott Gottlieb, MD, the Commissioner of the U.S. Food & Drug Administration (FDA) on the importance of “Listening to patients” and on how patients’ perspectives can inform drug development, drug review, and physicians’ prescribing habits. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: development, drug, opinion, patient, regulation | 1 Comment »
A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information (PPI) in determining patient perceptions of the “value” of high-intensity focused ultrasound (HIFU) and similar techniques in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: approval, benefit, devices, FDA, HIFU, information, medical, patient, preference, risk | Leave a comment »
A new analysis of data from men treated for their prostate cancer between 1992 and 2009 has provided additional information with respect to risks for long-term side effects of androgen deprivation therapy (ADT). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ADT, adverse, androgen, deprivation, effects, risk, side | 4 Comments »
Ellen’s husband of 40+ years died just over a week ago from metastatic prostate cancer. We offer her our sincere condolences. We also thought that many of our readers might want to see what Ellen wrote to Ask Amy last night (click here).
Filed under: Uncategorized | 4 Comments »
In a new lecture on the UroToday web site, Dr. Judd Moul of Duke University presents a passionate plea for better data on the relevance of PSA-based screening for risk of prostate cancer among African Americans. … READ MORE …
Filed under: Diagnosis, Risk | 7 Comments »
